Cargando…
Novel oral contraceptive for heavy menstrual bleeding: estradiol valerate and dienogest
Abnormal uterine bleeding (AUB) is associated with significant direct medical costs and impacts both society and the quality of life for individual women. Heavy menstrual bleeding, a subset of AUB, also referred to as menorrhagia, is defined as menstrual blood loss greater than 80 mL or the patient’...
Autores principales: | Rafie, Sally, Borgelt, Laura, Koepf, Erin R, Temple-Cooper, Mary E, Lehman, K Joy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3684222/ https://www.ncbi.nlm.nih.gov/pubmed/23788843 http://dx.doi.org/10.2147/IJWH.S31922 |
Ejemplares similares
-
Contraception with estradiol valerate and dienogest: adherence to the method
por: Fruzzetti, Franca, et al.
Publicado: (2019) -
Estradiol valerate and dienogest: a new approach to oral contraception
por: Kiley, Jessica W, et al.
Publicado: (2011) -
Endometrial safety of an oral contraceptive containing estradiol valerate and dienogest
por: Bitzer, Johannes, et al.
Publicado: (2011) -
An overview of the development of combined oral contraceptives containing estradiol: focus on estradiol valerate/dienogest
por: Fruzzetti, Franca, et al.
Publicado: (2012) -
Impact of estradiol-valerate/dienogest on work productivity and activities of daily living in European and Australian women with heavy menstrual bleeding
por: Wasiak, Radoslaw, et al.
Publicado: (2012)